Search
Bristol-Myers Squibb Co
BMYAdd to Watchlist
54.000USD
-1.270-2.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
110.27BMarket Cap
15.12P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Bristol-Myers Squibb Co is 6.94, ranking 120 out of 157 in the Pharmaceuticals industry. The average price target is 53.00, with a high of 68.00 and a low of 33.10.
Analyst Rating
Based on
32
analysts
Hold
Current Rating
62.057
Target Price
+12.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Bristol-Myers Squibb Co
BMY
32
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Bristol-Myers Squibb Co's expected revenue for the next quarter?
Bristol-Myers Squibb Co's expected revenue is 11.69B.
What is Bristol-Myers Squibb Co's price target?
Analysts forecast that Bristol-Myers Squibb Co's price target is USD 53.00, with the highest forecast at USD 68.00 and the lowest forecast at USD 33.10.
How have Bristol-Myers Squibb CoBMY's recent earnings per share performed?
The market expectation was USD 1.31, while Bristol-Myers Squibb CoBMY's earnings per share (EPS) for the previous quarter was USD 0.53. EPS for the next quarter is expected at USD 1.60.
What is the analyst rating for Bristol-Myers Squibb Co?
Based on the ratings of Bristol-Myers Squibb Co's stock from 32 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
